Gilead Sciences Inc (NASDAQ:GILD)
| 73.78 BATS BZX Real-Time Price As of 3:23pm ET |  -1.19 / -1.59%Today’s Change | 61.45 Today|||52-Week Range 89.74 | -14.06% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 12.9B | 8.2B | 7.6B | 17.9B | |
| Short Term Investment Cash | 2.8B | -4.6B | -641.0M | 10.4B | ||
| Cash & Short Term Investments | 14.6B | 11.9B | 26.1B | 31.0B | ||
| Receivables | Receivables | 5.9B | 4.5B | 3.9B | 3.3B | |
| Inventories | Inventories | 2.0B | 1.6B | 801.0M | 814.0M | |
| Current Assets | Prepaid Expenses | 1.0B | 530.0M | -- | -- | |
| Other Current Assets | 1.3B | 1.9B | 1.0B | 743.0M | ||
| Current Assets | 24.8B | 20.4B | 31.8B | 35.8B | ||
| Total Assets | Property, Plant and Equipment - Gross | 3.0B | 3.7B | 4.3B | 5.2B | |
| Depreciation | -763.0M | -818.0M | -994.0M | -1.2B | ||
| Intangible Assets | 11.4B | 10.1B | 21.3B | 19.9B | ||
| Other Assets | 12.9B | 12.8B | 24.0B | 22.3B | ||
| Total Assets | 51.8B | 57.0B | 70.3B | 63.7B | ||
| Liabilities | Accounts Payable | 1.2B | 1.2B | 814.0M | 790.0M | |
| Short Term Debt | 983.0M | 0.00 | 2.7B | 2.7B | ||
| Accrued Expenses | 6.8B | 7.8B | 6.9B | 6.3B | ||
| Other Current Liabilities | 7.3B | 8.0B | 6.9B | 6.3B | ||
| Other Liabilities | 9.9B | 9.2B | 11.6B | 10.6B | ||
| Total Liabilities | Long Term Debt | 21.2B | 26.3B | 30.8B | 24.6B | |
| Deferred Taxes | -324.0M | -402.0M | -27.0M | -- | ||
| Other Liabilities | 1.6B | 2.0B | 7.4B | 7.0B | ||
| Total Liabilities | 32.7B | 37.6B | 49.8B | 42.1B | ||
| Equity | Minority Interest | -2.0M | -13.0M | -16.0M | -5.0M | |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 18.5B | 18.9B | 20.4B | 21.4B | ||
| Total Shareholder Equity | 18.5B | 18.9B | 20.4B | 21.4B | ||
| Share Information | Common Shares Outstanding | 1.4B | 1.3B | 1.3B | 1.3B | |
| Addtl. Info. | No data currently available for this section. | |||||
